20.40
price up icon16.91%   2.95
after-market Handel nachbörslich: 21.99 1.59 +7.79%
loading

Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
51.87%
8.463
17.58 12.72 7.497 26.11
Operating Expenses
9.90%
19.15
21.26 22.21 21.59 23.33
Benefits Costs and Expenses
100.00%
-
20.73 21.59 20.97 -
Costs And Expenses
7.61%
19.15
20.73 21.59 20.97 23.33
Depreciation and Amortization
9.09%
0.036
0.033 0.022 0.025 0.032
Operating Income/Loss
190.83%
-10.69
-3.676 -9.49 -14.10 2.781
Income/Loss From Continuing Operations Before Tax
368.75%
8.463
-3.149 -8.877 -13.47 26.11
Income Tax Expense/Benefit
100.00%
-
0.064 0.23 0.149 -
Income/Loss From Continuing Operations After Tax
221.38%
-10.33
-3.213 -9.107 -13.62 3.013
Net Income/Loss
221.38%
-10.33
-3.213 -9.107 -13.62 3.013
Preferred Stock Dividends And Other Adjustments
-
- - - 0.636
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
337.59%
4.5378
1.037 90.29 90.12 78.64
Diluted Average Shares
337.59%
4.5378
1.037 90.29 90.12 101.19
Basic Earnings Per Share
7,500%
-2.28
-0.03 -0.10 -0.15 0.03
Diluted Earnings Per Share
7,500%
-2.28
-0.03 -0.10 -0.15 0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - 0.677
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Kapitalisierung:     |  Volumen (24h):